Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000044

Options or other derivatives

  • Chief Commercial Officer acquired 77,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Milanova Tsveta · Chief Commercial Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-03-01 Grant or award : show line 1 in the form Restricted stock units +17,000 17,000 D
2024-03-01 Grant or award : show line 2 in the form Stock options (right to buy) +60,000 60,000 D
Loading xslF345X05/wk-form4_1709672778.xml…